Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
Torka P, Kambhampati S, Chen L, Wang X, Chen C, Vuong D, Qin H, Muir A, Orand K, Borja I, Lynne Smith D, Herrera AF, Spurgeon SEF, Park B, Lewis LD, Hernandez-Ilizaliturri F, Xia Z, Danilov AV.
Torka P, et al. Among authors: lewis ld.
Blood Cancer J. 2023 Jan 11;13(1):9. doi: 10.1038/s41408-022-00763-w.
Blood Cancer J. 2023.
PMID: 36631449
Free PMC article.